A Systematic Review of Outcomes and Patient Satisfaction Following Surgical and Non-surgical Treatments for Hair Loss
- 243 Downloads
This systematic review aims to examine surgical and non-surgical treatments and identify those procedures that are most effective in terms of patient satisfaction.
Materials and Methods
A systematic review protocol was developed a priori in accordance with the Preferred Reporting for Items for Systematic Reviews and Meta-Analyses-Protocols (PRISMA-P) guidelines. The search was conducted in accordance with the PRISMA guidelines, the Cochrane handbook. A multistep search of the PubMed, MEDLINE, Embase, PreMEDLINE, Ebase, CINAHL, PsycINFO, and Cochrane databases was performed to identify studies on hair loss causes and hair loss treatment with different surgical and non-surgical techniques
Our search generated a total of 781 articles; 646 studies were excluded based on the content of the abstracts, and an additional 105 studies were excluded based on the content of the complete article. We performed a review of the 30 remaining studies, which had sufficient data for inclusion, and met all the aforementioned inclusion criteria. Of the 30 studies, four were about minoxidil, four about finasteride, two about dutasteride, three about phototherapy, six about platelet-rich plasma injection, four about follicular unit transplantation technique, six about follicular unit extraction technique, and one about patient satisfaction following surgical treatment without a specified surgical technique. Only three studies used a patient-reported outcome measurement.
Our study is the first comprehensive systematic review of hair loss, looking at the problem from different points of view, and focusing on finding the best solution for the patient. In the literature, there is currently no algorithm for the management of patients who go to a plastic surgeon for a solution to the problem of hair loss.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
KeywordsHair loss Hair transplantation FACE-Q Body image Plastic surgery Quality of life Bioethics
No intramural or extramural funding supported any aspect of this work.
Compliance with Ethical Standards
Conflict of interest
Authors declare that they have no conflict of interest to disclose.
Human and Animal Rights or Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
For this type of study, informed consent is not required.
- 7.Higgins J, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1. 0 (updated March 2011). The Cochrane CollaborationGoogle Scholar
- 9.Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ (2002) A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 47(3):377–385CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, Zhang P, Kohut B (2007) A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 57(5):767–774CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ (1998) Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 39(4 Pt 1):578–589CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, Kraus S, Baldwin H, Shalita A, Draelos Z, Markou M, Thiboutot D, Rapaport M, Kang S, Kelly T, Pariser D, Webster G, Hordinsky M, Rietschel R, Katz HI, Terranella L, Best S, Round E, Waldstreicher J (1999) Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 40(6 Pt 1):930–937CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, Stough D, DeVillez R, Rietschel R, Savin R, Bergfeld W, Swinehart J, Funicella T, Hordinsky M, Lowe N, Katz I, Lucky A, Drake L, Price VH, Weiss D, Whitmore E, Millikan L, Muller S, Gencheff C et al (1999) Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol 41(4):555–563PubMedPubMedCentralGoogle Scholar
- 18.Gubelin Harcha W, Barboza Martínez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, Barnes A, Ferron-Brady G, Chetty D (2014) A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol 70(3):489.e3–498.e3CrossRefGoogle Scholar
- 21.Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, Schachner LA (2014) Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol 15(2):115–127CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Gentile P, Scioli MG, Bielli A, De Angelis B, De Sio C, De Fazio D, Ceccarelli G, Trivisonno A, Orlandi A, Cervelli V, Garcovich S (2019) Platelet-rich plasma and micrografts enriched with autologous human follicle mesenchymal stem cells improve hair Re-growth in androgenetic alopecia. Biomolecular pathway analysis and clinical evaluation. Biomedicines 7(2):27CrossRefGoogle Scholar
- 24.Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG, Orlandi A, Gentile P (2014) The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int 2014:760709. https://doi.org/10.1155/2014/760709 CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Rodrigues BL, Montalvão SAL, Cancela RBB2, Silva FAR, Urban A, Huber SC, Júnior JLRC, Lana JFSD, Annichinno-Bizzacchi JM (2019) Treatment of male pattern alopecia with platelet-rich plasma: a double-blind controlled study with analysis of platelet number and growth factor levels. J Am Acad Dermatol 80(3):694–700CrossRefPubMedPubMedCentralGoogle Scholar
- 42.U.S. Food and Drug Administration. Guidance for Industry (2006) Patient-reported outcome measures: use in medical prod- uct development to support labeling claims. FDA web site. https://www.fda.gov/cder/guidance/index
- 44.Phillips TG, Slomiany WP, Allison R (2017) Hair loss: common causes and treatment. Am Fam Physician 96(6):371–378Google Scholar
- 47.Kaufman KD, Girman CJ, Round EM, Johnson-Levonas AO, Shah AK, Rotonda J (2008) Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients. Eur J Dermatol 18(4):407–411PubMedPubMedCentralGoogle Scholar
- 55.Randall V (2000) The biology of androgenetic alopecia. In: Camacho F, Randall VA (eds) Hair and its disorders: biology, pathology and management. Martin Dunitz, London, pp 123–136Google Scholar
- 62.Nakanishi S, Adachi I, Takayasu K (1996) Expression of androgen receptor, type I and type II 5a-reductase in human dermal papilla cells. In: Neste D (ed) Hair research for the next millennium. VREPB, Amsterdam, pp 333–337Google Scholar
- 68.Garza LA, Liu Y, Yang Z, Alagesan B, Lawson JA, Norberg SM, Loy DE, Zhao T, Blatt HB, Stanton DC, Carrasco L, Ahluwalia G, Fischer SM, FitzGerald GA, Cotsarelis G (2012) Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia. Sci Transl Med 4:126ra34Google Scholar